B
Bangkok Lab and Cosmetic PCL
SET:BLC
Bangkok Lab and Cosmetic PCL
SET:BLC
Price:
3.88
THB
2.65%
Market Closed
Market Cap:
฿2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
TH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
CH |
|
Dyne Therapeutics Inc
NASDAQ:DYN
|
US |
|
CloudMD Software & Services Inc
XTSX:DOC
|
CA |
|
A
|
American Campus Communities Inc
F:FGA
|
US |
|
B
|
Berli Jucker PCL
SET:BJC
|
TH |
|
AngioDynamics Inc
NASDAQ:ANGO
|
US |
|
Applied Industrial Technologies Inc
NYSE:AIT
|
US |
|
P
|
Pathward Financial Inc
SWB:FM7
|
US |
|
H
|
Hydrogene De France SA
PAR:HDF
|
FR |
|
Cedar Fair LP
NYSE:FUN
|
US |
Multiples-Based Value
The Multiples-Based Value of one BLC stock under the Base Case scenario is hidden THB. Compared to the current market price of 3.88 THB, Bangkok Lab and Cosmetic PCL is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BLC Multiples-Based Value
LOCKED
Multiples Across Competitors
BLC Competitors Multiples
Bangkok Lab and Cosmetic PCL Competitors
Bangkok Lab and Cosmetic PCL Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TH |
B
|
Bangkok Lab and Cosmetic PCL
SET:BLC
|
2.3B THB | 1.4 | 13.5 | 8.3 | 10.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.5 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.1 | 7.5 | 8.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
